EUVIMEDEUVIMED entdecken
Vergleichsstudie

Patients with status epilepticus and new‐onset refractory status epilepticus display drastically altered fecal microbiomes compared to chronic epilepsy patients

Claude Steriade iD, Scott C Thomas iD, Fangxi Xu, Amit Ahituv, Aurélie Hanin, Maria Pleshkevich, Samantha Hwang, Alexandra Ramirez, Brandon Foreman, Ji Yeoun Yoo iD, Onome Eka, Marissa Kellogg und 7 weitere

Epilepsia · 2025

DOI: 10.1111/epi.18450 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Epilepsia, 2025. Verfasst von Claude Steriade und 18 weiteren Autor:innen. Beteiligte Einrichtung: New York University Comprehensive Epilepsy Center, Department of Neurology, New York University, New York, New York, USA. Hauptthemen laut MEDLINE: Status Epilepticus, Gastrointestinal Microbiome, Feces, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: NORSE Institute, the Daniel Raymond Wong Memorial Research Fund and CCEMRC, Parekh Center for Interdiscplinary Neurology, National Organization for Rare Disorders and American Epilepsy Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

New‐onset refractory status epilepticus (NORSE) occurs in people without pre‐existing epilepsy or a rapidly identified structural, toxic, metabolic, or other cause. NORSE is a rare disorder with high morbidity and mortality rates and limited evidence for effective therapies. We aimed to assess whether the gut microbiome of NORSE and status epilepticus (SE) differs from that of chronic epilepsy, whether NORSE differs from SE at different disease time points, and to examine the correlations between specific gut microbiota and cytokines in NORSE and SE.

Methods

This longitudinal cohort study observed patients with NORSE ( n = 15), SE ( n = 17), and chronic epilepsy who were not in SE ( n = 12). NORSE patients were recruited through the NORSE Consortium. Patients with NORSE and SE underwent longitudinal serial biospecimen collection. Fecal samples were subjected to whole‐community shotgun metagenomics to characterize microbiome features. Cohorts were evaluated for prokaryotic, eukaryotic, and functional diversity. Correlations between blood inflammatory cytokine levels and microbiome features and covariate analysis with critical illness and clinical treatments were examined for NORSE and SE patients during and after SE resolution.

Results

During SE, NORSE and SE patients had significantly different prokaryotic, eukaryotic, and functional microbiome levels compared to chronic epilepsy patients without SE. Limited microbiome differences were observed within and between NORSE and SE, although these groups displayed differing correlation patterns between microbial species and cytokines. Patients who later died or were tube‐fed harbored significantly different microbiomes than those who survived or were orally fed. Significance NORSE and SE patients present with a more variable and dramatically different fecal microbiome than chronic epilepsy patients, which may indicate gut dysbiosis that may be reciprocally linked to inflammatory responses. Although NORSE and SE patients had similar microbiome structures, fungal and bacterial correlates with inflammatory cytokines differed between NORSE and SE, with confounding factors influencing microbiome structure. Our data suggest a microbiome‐specific response to NORSE and SE, with implications for future treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusGastrointestinal MicrobiomeFecesEpilepsyDrug Resistant EpilepsyHumansMaleFemaleAdultMiddle AgedLongitudinal StudiesChronic DiseaseCohort StudiesYoung AdultCytokinesAged

Stichwörter der Autor:innen

NORSEcytokinesgut microbiomeneuroinflammationstatus epilepticus

Substanzen

Cytokines

Autor:innen und Institutionen

  • New York University Comprehensive Epilepsy Center, Department of Neurology, New York University, New York, New York, USA.
  • Neuroscience Institute, New York University, New York, New York, USA.
  • Department of Molecular Pathobiology, New York University College of Dentistry, New York, New York, USA.
  • Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Institut du Cerveau, ICM, Sorbonne Université, CNRS UMR 7225, INSERM U1127, Pitié-Salpêtrière Hospital, Paris, France.
  • University of Cincinnati, Cincinnati, Ohio, USA.

ORCID-Profile: Claude Steriade, Scott C Thomas, Ji Yeoun Yoo, Lawrence J Hirsch, Deepak Saxena

Förderung

  • NORSE Institute, the Daniel Raymond Wong Memorial Research Fund and CCEMRC
  • Parekh Center for Interdiscplinary Neurology
  • National Organization for Rare Disorders and American Epilepsy Society
  • National Organization for Rare Disorders

Zitieren

APA

Steriade, C., Thomas, S. C., Xu, F., Ahituv, A., Hanin, A., Pleshkevich, M., Hwang, S., Ramirez, A., Foreman, B., Yoo, J. Y., Eka, O., Kellogg, M., Oliger, A., Wainwright, M. S., Morales, M., Gaspard, N., Hirsch, L. J., Devinsky, O., & Saxena, D. (2025). Patients with status epilepticus and new‐onset refractory status epilepticus display drastically altered fecal microbiomes compared to chronic epilepsy patients. Epilepsia. https://doi.org/10.1111/epi.18450

Vancouver

Steriade C, Thomas SC, Xu F, Ahituv A, Hanin A, Pleshkevich M, et al. Patients with status epilepticus and new‐onset refractory status epilepticus display drastically altered fecal microbiomes compared to chronic epilepsy patients. Epilepsia. 2025. doi:10.1111/epi.18450

BibTeX
@article{Steriade2025,
  author = {Steriade, Claude and Thomas, Scott C and Xu, Fangxi and Ahituv, Amit and Hanin, Aurélie and Pleshkevich, Maria and Hwang, Samantha and Ramirez, Alexandra and Foreman, Brandon and Yoo, Ji Yeoun and Eka, Onome and Kellogg, Marissa and Oliger, Audrey and Wainwright, Mark S and Morales, Mikaela and Gaspard, Nicolas and Hirsch, Lawrence J and Devinsky, Orrin and Saxena, Deepak},
  title = {Patients with status epilepticus and new‐onset refractory status epilepticus display drastically altered fecal microbiomes compared to chronic epilepsy patients},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18450}
}
Kostenlos starten →